Amneal Pharmaceuticals, Inc. (AMRX) Profit Margin
Amneal Pharmaceuticals, Inc. (AMRX) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2017-12-31 | 16.36% |
| 2018-12-31 | -1.32% |
| 2019-12-31 | -20.65% |
| 2020-12-31 | 4.49% |
| 2021-12-31 | 0.50% |
| 2022-12-31 | -5.88% |
| 2023-12-31 | -3.51% |
| 2024-12-31 | -4.18% |
| 2025-12-31 | 2.39% |
How AMRX compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| ENSG | The Ensign Group Inc. | 6.80% |
| ADUS | Addus HomeCare Corporation | 6.74% |
| USPH | U.S. Physical Therapy Inc. | 5.07% |
| OGN | Organon & Co. | 3.01% |
| NVST | Envista Holdings Corporation | 1.73% |
These are five companies in the same sector as AMRX with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Amneal Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("AMRX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | AMRX | $17.68 | +1.20% | 1.35M |
| 3 | ||||
| 4 | ||||
| 5 |